Psoriasis—A Cancer Risk Factor?
Source abstract
Abstract
Psoriasis is not considered a strictly skin condition, but a complex disease with multisystem involvement due to the frequent associated comorbidities. We conducted a retrospective database study of 10,986 patients admitted in the interval January 2008–January 2019 to the Dermatology Clinic of the Iasi County “St. Spiridon” Emergency Hospital. Of the 10,986 patients admitted, 1288 were diagnosed with psoriasis. The association of malignancies was found in 40 of the psoriasis group cases and 399 of the control group cases that included various dermatological conditions. The calculation of Odds Ratios allowed us to determine if the patients with psoriasis could be at risk for certain malignancies. Thus, an association was suggested between psoriasis and central nervous system (CNS), upper aerodigestive tract cancer, endocrine cancer, bladder cancer, lung cancer, prostate cancer, breast cancer, or colorectal cancer. It is the first study of its kind in the northeastern region of Romania and can be the starting point for future long-term prospective cohort studies that will allow a more accurate data collection and a better understanding of the psoriasis–cancer relationship.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Psoriasis: Treatment and Pathogenesis · Vitamin D Research Studies · Dermatology and Skin Diseases
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Dermatology, University of Medicine and Pharmacy ‘Grigore T. Popa’, 700115 Iași, Romania
‘Sf. Spiridon’ Clinical Emergency County Hospital, 700115 Iași, Romania
References (61)
Show source-provided references
1. Global Epidemiology of Psoriasis: A Systematic Review of Incidence and Prevalence10.1038/jid.2012.339 ↗
2. National Psoriasis Foundation clinical consensus on psoriasis comorbidities and recommendations for screening10.1016/j.jaad.2008.01.006 ↗
3. Psoriasis10.1056/NEJMra0804595 ↗
4. Risk of cancer in psoriasis: A systematic review and meta-analysis of epidemiological studies10.1111/jdv.12165 ↗
5. Association of Psoriasis With the Risk of Developing or Dying of Cancer: A Systematic Review and Meta-analysis10.1001/jamadermatol.2019.3056 ↗
6. The risk of malignancy associated with psoriasis
7. Psoriasis and Risk of Incident Cancer: An Inception Cohort Study with a Nested Case–Control Analysis10.1038/jid.2009.113 ↗
8. Cancer Risk Evaluation in Psoriasis: In Search of the Holy Grail?10.1038/jid.2009.203 ↗
9. Association between psoriasis and incident cancer: The Iowa’s Women’s Health Study10.1007/s10552-011-9773-0 ↗
10. Trioxsalen bath PUVA did not increase the risk of squamous cell skin carcinoma and cutaneous malignant melanoma in a joint analysis of 944 Swedish and Finnish patients with psoriasis10.1046/j.1365-2133.1999.03044.x ↗
11. Psoriasis, its Treatment, and Cancer in a Cohort of Finnish Patients10.1046/j.1523-1747.2000.00898.x ↗
12. Cancer risk in hospitalised psoriasis patients: A follow-up study in Sweden10.1038/sj.bjc.6605027 ↗
13. The prevalence of malignant tumors in patients with psoriasis10.1016/0190-9622(90)70152-8 ↗
14. Prevalence, Incidence, and Risk of Cancer in Patients With Psoriasis and Psoriatic Arthritis: A Systematic Review and Meta-analysis10.1001/jamadermatol.2020.0024 ↗
15. Risk of Malignancies in Psoriasis Patients Treated with Cyclosporine: A 5 y Cohort Study10.1046/j.1523-1747.2003.12040.x ↗
16. Malignancy Risk and Recurrence with Psoriasis and Its Treatments: A Concise Update10.1007/s40257-017-0337-2 ↗
17. The risk of cancer in patients with psoriasis: A population-based cohort study in Taiwan10.1016/j.jaad.2010.04.046 ↗
18. Epidemiology and comorbidities of psoriasis patients in a national database in Taiwan10.1016/j.jdermsci.2011.03.002 ↗
19. Cancer Risk in a Population-Based Cohort of Patients Hospitalized for Psoriasis in Sweden10.1046/j.0022-202x.2001.01520.x ↗
20. Cancer risk in 892 089 patients with psoriasis in Korea: A nationwide population-based cohort study10.1111/1346-8138.14698 ↗
21. Noncutaneous malignant tumors in the PUVA follow-up study: 1975–199610.1111/1523-1747.ep12292698 ↗
22. Complete resolution of psoriasis vulgaris after excision of thyroid cancer10.1111/j.1365-4362.1997.tb03044.x ↗
23. The Risk of Cancer in Patients With Psoriasis: A Population-Based Cohort Study in the Health Improvement Network10.1001/jamadermatol.2015.4847 ↗
24. Risk and predictors of psoriasis in patients with breast cancer: A Swedish population-based cohort study10.1186/s12916-017-0915-4 ↗
25. Malignant tumors in patients with psoriasis10.1016/0190-9622(92)70244-A ↗
26. Differential Effects of Aspirin before and after Diagnosis of Colorectal Cancer10.1001/jama.2013.6600 ↗
27. C-Reactive Protein and the Risk of Incident Colorectal Cancer10.1001/jama.291.5.585 ↗
28. Higher Incidence of Abnormal Pap Smears in Women with Inflammatory Bowel Disease10.1111/j.1572-0241.2007.01582.x ↗
29. Prevalence and cervical human papilloma virus associated factors in patients with rheumatoid arthritis
30. Systemic lupus erythematosus, human papillomavirus infection, cervical pre-malignant and malignant lesions: A systematic review10.1007/s10067-010-1606-0 ↗
31. Cervical human papillomavirus infection in Mexican women with systemic lupus erythematosus or rheumatoid arthritis
32. Risk of high-grade cervical dysplasia and cervical cancer in women with systemic inflammatory diseases: A population-based cohort study10.1136/annrheumdis-2013-204993 ↗
33. Psoriasis and comorbid diseases: Implications for management10.1016/j.jaad.2016.07.065 ↗
34. The Increased Risk of Skin Cancer Is Persistent after Discontinuation of Psoralen+Ultraviolet A: A Cohort Study10.1046/j.1523-1747.2003.12350.x ↗
35. The risk of squamous cell and basal cell cancer associated with psoralen and ultraviolet A therapy: A 30-year prospective study10.1016/j.jaad.2011.04.004 ↗
36. High single-dose European PUVA regimen also causes an excess of non-melanoma skin cancer10.1111/j.1365-2133.1991.tb03281.x ↗
37. The Risk of Lymphoma in Patients with Psoriasis10.1038/sj.jid.5700410 ↗
38. Lymphoma Rates Are Low but Increased in Patients With Psoriasis: Results from a population-based cohort study in the United Kingdom10.1001/archderm.139.11.1425 ↗
39. Lymphoma Risk in Psoriasis: Results of the PUVA follow-up study10.1001/archderm.142.9.1132 ↗
40. Risk of malignant lymphomas in patients with rheumatoid arthritis and in their first-degree relatives10.1002/art.10939 ↗
41. The risk of malignancy among biologic-naïve pediatric psoriasis patients: A retrospective cohort study in a US claims database10.1016/j.jaad.2017.03.044 ↗
42. Carcinogenic risks of Psoralen UV-A therapy and Narrowband UV-B therapy in chronic plaque psoriasis: A systematic literature review10.1111/j.1468-3083.2012.04520.x ↗
43. An Australian/New Zealand Narrative10.1111/ajd.12889 ↗
44. Melanoma and non-melanoma skin cancer in psoriatic patients treated with high-dose phototherapy10.3109/09546634.2015.1133882 ↗
45. Cutaneous neoplasia following PUVA therapy for psoriasis10.1111/j.1365-2133.1996.tb06962.x ↗
46. Reduced frequency of melanoma in 72,739 patients with psoriasis: A retrospective study10.1684/ejd.2014.2501 ↗
47. Anti-inflammatory Agents: Present and Future10.1016/j.cell.2010.02.043 ↗
48. Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine10.1136/gut.2004.049460 ↗
49. Meta-Analysis of Risk of Malignancy with Immunosuppressive Drugs in Inflammatory Bowel Disease10.1345/aph.1H219 ↗
50. Cyclosporine and skin cancer: An international dermatologic perspective over 25 years of experience. A comprehensive review and pursuit to define safe use of cyclosporine in dermatology10.3109/09546634.2011.590792 ↗
51. Incidence of melanoma and other malignancies among rheumatoid arthritis patients treated with methotrexate10.1002/art.23716 ↗
52. Long-term safety of methotrexate monotherapy in patients with rheumatoid arthritis: A systematic literature research10.1136/ard.2008.093690 ↗
53. Pharmacologic Immunomodulation and Cutaneous Malignancy in Rheumatoid Arthritis, Psoriasis, and Psoriatic Arthritis10.3899/jrheum.100041 ↗
54. Cumulative exposure to biological therapy and risk of cancer in patients with psoriasis: A meta-analysis of Psonet studies from Israel, Italy, Spain, the U.K. and Republic of Ireland10.1111/bjd.16715 ↗
55. The risk of infection and malignancy with tumor necrosis factor antagonists in adults with psoriatic disease: A systematic review and meta-analysis of randomized controlled trials10.1016/j.jaad.2010.09.734 ↗
56. Risk of cancer in patients with psoriasis on biological therapies: A systematic review10.1111/bjd.15830 ↗
57. Cause-specific mortality in patients with severe psoriasis: A population-based cohort study in the U.K10.1111/j.1365-2133.2010.09941.x ↗
58. Survival in cancer patients hospitalized for psoriasis: A population-based cohort study in Sweden10.1111/j.1365-2133.2011.10268.x ↗
59. The risk of melanoma and hematologic cancers in patients with psoriasis10.1016/j.jaad.2016.09.047 ↗
60. Molecular Dissection of Psoriasis: Integrating Genetics and Biology10.1038/jid.2009.319 ↗
61. Cancer risk in immune-mediated inflammatory diseases (IMID)10.1186/1476-4598-12-98 ↗